Experimental and Therapeutic Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-06-22 ms5000000364586422

审稿速度:6.0 | 投稿命中率:50.0
经验分享：接收8个月了，一直in production，发咨询邮件也不回复

104 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-07-16 ms8000001135633638

刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么

86 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-04-29 李晓刚

哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-07-15 ghyang.cardiolab

投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-07-15 ghyang.cardiolab

投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀

37 0

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-04-29 浪花一朵朵

官方邮件啊李晓刚 2020-04-29 发表::
你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表:
你二审修回大的邮件吗？发的哪个邮件？谢谢

李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-06-11 Dawnstar

投稿命中率:50.0
经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑

91 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-07-05 扫地医生

审稿速度:12.0 | 投稿命中率:75.0
偏重的研究方向：医学综合期刊
经验分享：希腊系列期刊，对国人友好

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-07-03 7yl3r

去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。

29 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=799359, encodeId=4817e99359ed, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：接收8个月了，一直in production，发咨询邮件也不回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200907/5e2ae8ab60144029a95cc6c18a379ac1/022cee82a6fa4b7487cb2c3e007d4e48.jpg, createdBy=9fbf96637, createdName=ms5000000364586422, createdTime=Mon Jun 22 12:32:02 CST 2020, time=2020-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803004, encodeId=e78980300462, content=刚投稿，只给注册账户发邮件了，请问其他作者和通讯会收到邮件么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f8f5342348, createdName=ms8000001135633638, createdTime=Thu Jul 16 19:12:55 CST 2020, time=2020-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589908, encodeId=c04658990801, content=哪位大神知道修回是回复哪个邮件？前几天直接回复他们来的邮件，今天又收到催我回复一审意见，说如果已经回复请忽略此邮件！不知道他们到底收没收到啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5392304852, createdName=李晓刚, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802843, encodeId=5c0780284390, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Not yet available，这正常吗，是被拒了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 09:38:58 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802832, encodeId=90e7802832a0, content=投稿 1周了，Status是Internal Editor Decision，Letter of acceptance是Letter of acceptance，这正常吗，这个状态要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=837d1442169, createdName=ghyang.cardiolab, createdTime=Wed Jul 15 08:56:23 CST 2020, time=2020-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589907, encodeId=43a958990e88, content=官方邮件啊李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢李晓刚 2020-04-29 00:00:00 发表: 你二审修回大的邮件吗？发的哪个邮件？谢谢, beContent=李晓刚 2020-04-29 发表:: 你二审修回大的邮件吗？发的哪个邮件？谢谢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a424661104, createdName=浪花一朵朵, createdTime=Wed Apr 29 00:00:00 CST 2020, time=2020-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602080, encodeId=e8c96020802c, content=投稿命中率:50.0 经验分享：去年九月接受到现在都还没有见刊最近几个月发邮件也不回复劝大家避坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/11/09/11b0952e716c73d9f739e2c36fef9b3f.jpg, createdBy=2ef92193587, createdName=Dawnstar, createdTime=Thu Jun 11 23:29:32 CST 2020, time=2020-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801388, encodeId=b8f28013884a, content=审稿速度:12.0 | 投稿命中率:75.0 偏重的研究方向：医学综合期刊 经验分享：希腊系列期刊，对国人友好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=69b01651121, createdName=扫地医生, createdTime=Sun Jul 05 22:04:39 CST 2020, time=2020-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801019, encodeId=490f80101956, content=去年12月投稿，今年3月一审修回，6月底接收，过了一周以动物实验不符合伦理要求拒稿，劝大家避坑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200703/7d0917b6c6384660ada197c9b3f5f615/a2593f1dbc5c486e92e19389dee1b902.jpg, createdBy=39d45391966, createdName=7yl3r, createdTime=Fri Jul 03 08:29:58 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800957, encodeId=6acc80095eae, content=请问大家这本杂志的文章有没有wos号呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/9e36f041f51c4285b898155d2cc8be07/408e399534a44b92b461c5b08db55646.jpg, createdBy=5b4f2438170, createdName=三藏爱吃肉, createdTime=Thu Jul 02 20:38:14 CST 2020, time=2020-07-02, status=1, ipAttribution=)]

2020-07-02 三藏爱吃肉

请问大家这本杂志的文章有没有wos号呀

30 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务